Intrinsiqq
Financière de Tubize SA logo

Financière de Tubize SA Financials

TUB.XBRU

Compare

All currency values in € millions unless otherwise noted

Scroll

Income Statement
DEC 2025
DEC 2024
DEC 2023
DEC 2022
DEC 2021
Revenues
Revenue€0€0€0€0€0
Cost of Revenue€3€2€2€2€1
Gross Profit-€3-€2-€2-€2-€1
Total Operating Expenses€0-€0€0-€0€0
Operating Income-€3-€2-€2-€2-€2
Non-Operating
Net Interest Expense-€1-€2-€2-€2-€1
Income Tax Expense€0€0€0€0€0
Net Income
Net Income€93€90€88€85€84
Per Share Data
Revenue Per Share€0.00€0.00€0.00€0.00€0.00
EPS (Basic)€2.09€2.02€1.98€1.91€1.88
EPS (Diluted)€2.09€2.02€1.98€1.91€1.88
Shares Outstanding44.5M44.5M44.5M44.5M44.5M
Dividends Per Share€1.08€1.04€0.97€0.86€0.75

Financière de Tubize SA (TUB.XBRU) financials: revenue, profit and margins

Financière de Tubize SA (TUB.XBRU) generated about €0.00 in revenue and €93 million in net income over the trailing twelve months. Figures are from company filings; this is analysis, not investment advice.

Frequently asked

What is Financière de Tubize SA's (TUB.XBRU) revenue?+

Financière de Tubize SA generated about €0.00 in revenue over the trailing twelve months. Revenue is the top line, before any costs; what matters for value is how much of it survives to free cash flow. The full income statement, balance sheet and cash-flow statement are on this tab.

Is Financière de Tubize SA profitable?+

Yes, Financière de Tubize SA reported about €93 million in net income over the trailing twelve months. Net income is the bottom line after all costs, interest and taxes. Compare it to free cash flow on this tab, since reported profit and actual cash generated can diverge.

How the market compares: How many US companies are profitable

Peers

Biotechnology · Pick stocks to compare with TUB.XBRU

CompareIntrinsic value
SEQUA.XBRUSequana Medical NV
€0.61+0.00%0
BIOS.XBRUBioSenic SA
€0.00+0.00%0
OXUR.XBRUOxurion NV
€0.00+0.00%15
IBAB.XBRUIon Beam Applications SA
€16.06-1.59%46
HYL.XBRUHyloris Pharmaceuticals SA
€4.15-3.49%46
FAGR.XBRUFagron NV
€24.65+1.02%78
CYAD.XBRUCelyad Oncology SA
€0.16+0.62%20
ALEMS.XBRUEuropean Medical Solutions S.A.
€3.50+2.34%76

Held by ETFs

TUB.XBRU is in 38 US ETFs. The largest of them, with TUB.XBRU's weight in each:

Spot a number that looks wrong?

Download this analysis as a PDF (Pro)

Data sourced from company filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.

5 of 5 free stocks used today

Keep analysing TUB.XBRU

A free account gives you 10 stocks a day, a watchlist and price alerts.

Already have an account?

Or come back tomorrow. Stocks on your watchlist are always free to view.

MarketsPrivacyTerms© 2026 Intrinsiqq

Not financial advice. Analytical data for research only.

Intrinsiqq is a Netherlands-based company operating in Rotterdam, KvK 73238007.